Red blood cell-encapsulated L-asparaginase

DB17477InvestigationalProtein Based Therapies

Red blood cell-encapsulated L-asparaginase is Asparaginase Escherichia coli encapsulated inside donor-derived red blood cells, which target cancer cells capable of altering asparagine and glutamine metabolism. It is being investigated in...

Mechanism
Curator reviewed
Also known as
asparaginase encapsulated in erythrocytes · Erythrocyte encapsulated l-asparaginase · L-asparaginase encapsulated in red blood cells · RBC-encapsulated l-asparaginase

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Red blood cell-encapsulated L-asparaginase, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account